ALLMedicine™ Hypopharyngeal Cancer Center

May 13th, 2022 - Hypopharyngeal liposarcoma is an extremely rare entity, and yet fewer than 40 cases have been reported in the literature. Lacking the possibility of distant metastases, local surgical resection with a clear margin can achieve the purpose of treatm...

May 11th, 2022 - Background: Larynx preservation surgery (LPS) combined with multimodal adjuvant therapy (MAT) is re-emerging as treatment option for hypopharyngeal cancer (HPC). This study aims to explore the survival and functional outcome of this combined appro...

May 10th, 2022 - This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational drug to learn whether the drug works in treating a specific disease. "Investigational" means that the drug or combin...

May 4th, 2022 - Tobacco smoking is the most known risk factor for hypopharyngeal cancer. Bile reflux has recently been documented as an independent risk factor for NFκB-mediated hypopharyngeal squamous cell carcinoma. However, the carcinogenic effect of tobacco s...

Apr 8th, 2022 - Osteoradionecrosis of the cervical spine: an uncommon complication of radiation therapy for hypopharyngeal cancer.|2022|Bryce A,Williamson A,McArthur C,O'Neil G,|radiotherapy,etiology,

May 10th, 2022 - This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational drug to learn whether the drug works in treating a specific disease. "Investigational" means that the drug or combin...

Mar 23rd, 2020 - Patients with head and neck cancer treated with chemoradiation, often develop a treatment associated dysphagia. The common complaint is foods sticking in the pharynx. This study seeks to test the Iowa Oral Performance Instrument (IOPI) in the mana...

Dec 12th, 2017 - At the time of diagnosis, approximately 60%-80% of patients with hypopharyngeal cancer are found with cervical lymph node metastasis. Cervical nodal metastasis is an important prognostic factor in hypopharyngeal cancer. Induction chemotherapy is f...

Jan 16th, 2012 - OBJECTIVES: Primary To determine if the addition of concurrently administered panitumumab to standard adjuvant chemoradiation, with 1 of 2 cisplatin-based regimens, significantly prolongs disease-free survival of patients with macroscopically comp...

Mar 14th, 2006 - Carcinoma of unknown primary (CUP) is defined as biopsy-proven metastasis of an epithelial malignancy in the absence of an identifiable primary site after complete history and physical examination, basic laboratory studies, chest X-ray and additio...

Oct 6th, 2021 - Advances made in the field of radiation oncology are allowing patients with cancer to derive greater benefit with fewer toxicities, according to Eric M. Horwitz, MD, FABS, FASTRO, and Stephanie E. Weiss, MD, FASTRO. Many efforts being made at Fox ...

Dec 5th, 2020 - The bond between bevacizumab and vascular endothelial growth factor. More than 1800 oncology specialists and other healthcare professionals turned out for the annual National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines & Qua...

Dec 5th, 2020 - Each year the National Comprehensive Cancer Network (NCCN) presents the latest updates to its Clinical Practice Guidelines in Oncology, as well as the latest cancer therapies by key opinion leaders. This year’s event, held at The Westin Diplomat i...

Sep 4th, 2019 - Nasal polyps are common, affecting up to 4% of the general population, and can affect quality of life, but are usually benign. However, a new study suggests that when they occur in older patients (≥ 50 years) they may increase the risk of developi...

Nov 16th, 2010 - November 16, 2010 (San Diego, California) — Should hypopharynx cancer continue to be included in Radiation Therapy Oncology Group "multi head and neck" trials? Dr. Paul Busse (left) presents the award to Dr. Robert Den (right) For his work in prov...